J. Am. Acad. Dermatol. 2020 Jan 28
A prospective cohort study of Condensed low dose total skin electron beam therapy for mycosis fungoides: reduction of disease burden and improvement in quality of life.
Song A, Gochoco A, Zhan T, Sahu J, Alpdogan O, Porcu P, Nikbakht N, Shi W
Low-dose total skin electron beam therapy (TSEBT) for mycosis fungoides (MF) is popular due to reduced toxicity with effective palliation. We condense ...
Read More
Source: PubMed
J. Invest. Dermatol.
Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?
Scarisbrick JJ
Early-stage mycosis fungoides (MF) has been associated with long survival. A recent meta-analysis including 6,279 patients with MF and Sezary syndrome ...
Read More
Source: PubMed
PLoS ONE
Non-mycosis fungoides cutaneous lymphomas in a referral center in Taiwan: A retrospective case series and literature review.
Liu KL, Tsai WC, Lee CH
While mycosis fungoides (MF) and Sézary syndrome (SS) are the most common cutaneous lymphomas (CLs), there is limited data about non-MF/SS CLs. ...
Read More
Source: PubMed
J. Dermatol. 2020 Jan 23
Multiple seborrheic keratosis-like lesions of mycosis fungoides masquerading as the Leser-Trèlat sign.
Hagiwara R, Shinkuma S, Tomii K, Aizawa A, Abe R
Read More
Source: PubMed
Australas. J. Dermatol. 2020 Jan 22
An instructive case of amlodipine-induced reversible granulomatous CD30+ T-cell pseudolymphoma.
Cheong KW, Lim GZ, Tan KB, Lim JH
We report an unusual case of drug-associated granulomatous CD30+ T-cell pseudolymphoma secondary to amlodipine. A 55-year-old Chinese man presented wi ...
Read More
Source: PubMed
